1992
DOI: 10.1016/0090-4295(92)90450-b
|View full text |Cite
|
Sign up to set email alerts
|

Renal pelvic cancer: A review of 611 patients treated in Illinois 1975–1985

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
58
1
6

Year Published

2004
2004
2013
2013

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 109 publications
(69 citation statements)
references
References 27 publications
4
58
1
6
Order By: Relevance
“…4,5,12,15 Guinan et al, who reported the largest published series of >600 patients who were treated in Illinois, observed that the 5-year cancer-specific survival probabilities were 75% for patients with Ta/tumor in situ (Tis) tumors, 87% for patients with T1 and T2 tumors, 54% for patients with T3 tumors, and 19% for T4 patients. 5 More recently, Hall et al reported 5-year cancer-specific survival probabilities of 100% for patients with Ta/Tis tumors, 92% for patients with T1 tumors, 73% for patients with T2 tumors, and 41% for patients with T3 tumors. 4 With regard to histologic grade, data from the literature indicate 5-year cancer-specific survival probabilities in the range from 80% to 100% for patients with grade 1 UUT-TCC, from 33% to 94% for patients with grade 2 UUT-TCC, and from 11% to 40% for patients with grade 3 UUT-TCC.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…4,5,12,15 Guinan et al, who reported the largest published series of >600 patients who were treated in Illinois, observed that the 5-year cancer-specific survival probabilities were 75% for patients with Ta/tumor in situ (Tis) tumors, 87% for patients with T1 and T2 tumors, 54% for patients with T3 tumors, and 19% for T4 patients. 5 More recently, Hall et al reported 5-year cancer-specific survival probabilities of 100% for patients with Ta/Tis tumors, 92% for patients with T1 tumors, 73% for patients with T2 tumors, and 41% for patients with T3 tumors. 4 With regard to histologic grade, data from the literature indicate 5-year cancer-specific survival probabilities in the range from 80% to 100% for patients with grade 1 UUT-TCC, from 33% to 94% for patients with grade 2 UUT-TCC, and from 11% to 40% for patients with grade 3 UUT-TCC.…”
Section: Discussionmentioning
confidence: 99%
“…3 The knowledge of prognostic factors for UUT-TCC often is based on studies on the most common bladder TCC, and only a few studies on prognostic factors for UUT-TCC have been published to date, and those sometimes have reported conflicting data. Tumor stage [4][5][6][7][8][9][10][11] and histologic grade 7,11,12 are among the best established prognostic factors; whereas, conversely, the roles of other potentially relevant variables, such as a history of bladder cancer, tumor site, lymphovascular invasion, or multifocality, are less clear. [6][7][8]10,11 A clear knowledge of those prognostic data would be useful for counseling patients after surgery and for identifying those patients with unfavorable cancer-related outcome who may be candidates for future neoadjuvant or adjuvant randomized controlled trials.…”
mentioning
confidence: 99%
“…7 Our patient's UC was pathologically high grade and a pT3 lesion, with involvement of renal sinus fat via invasion through muscle. A renal pelvic location has improved survival in UC versus a ureteral primary, 8,9 though Holmang and Johansson 10 have suggested only 25% survival in high-grade pT3 upper tract UC. The UC was likely the more ominous primary lesion in this patient.…”
Section: Leveridge Et Almentioning
confidence: 99%
“…Data on distribution of stage and grade at initial presentation indicate that most patients present with a low stage (Ta-T1) grade 2 or 3 tumour [1,[6][7][8][9]. Stage and grade are the most important prognostic factors for recurrence and survival [7][8][9][10][11], but type of treatment [7] and multifocality [8,12], have also been reported to be important, to a variable extent.…”
Section: Introductionmentioning
confidence: 99%